Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News | Heart Failure

April 3, 2022 — Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering ...

Home April 03, 2022
Home
News | Heart Failure

April 1, 2022 — A new joint guideline published today from the American College of Cardiology, the American Heart ...

Home April 01, 2022
Home
News | Heart Failure

April 1, 2022 – The activation of the bone marrow appears to play a key role in the origin and development of ...

Home March 31, 2022
Home
News | ACC

April 1, 2022 —  Royal Philips, a global leader in health technology, announced new additions to its innovative ...

Home April 01, 2022
Home
MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March ...

Home March 31, 2022
Home
News | ESC

March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held ...

Home March 31, 2022
Home
News | Pharmaceuticals

March 31, 2022 – Windtree Therapeutics, a biotechnology company focused on advancing multiple late-stage interventions ...

Home March 31, 2022
Home
News | Embolization devices

March 31, 2022 – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...

Home March 31, 2022
Home
News | Structural Heart

March 31, 2022 – Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...

Home March 31, 2022
Home
News | Heart Failure

March 31, 2022 – One in 5 people worldwide have high Lipoprotein(a) – sometimes referred to as “L-P-little a” – an ...

Home March 31, 2022
Home
News | Population Health

March 31, 2022 – People living in socially-deprived areas of the United States are more likely to die prematurely from ...

Home March 31, 2022
Home
News | Sudden Cardiac Arrest

March 30, 2022 — Clinician-scientists in the Smidt Heart Institute at Cedars-Sinai developed a clinical algorithm that ...

Home March 30, 2022
Home
News | Embolization devices

March 29, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral ...

Home March 29, 2022
Home
Subscribe Now